Clinical Trials Sponsored by Qilu Pharmaceutical Co., Ltd.

Total 3758 results

Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Adenocarcinoma (PDAC)

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors

Solid Tumor

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study of QLF3108 in Participants With Advanced Solid Tumor

Advanced Solid Tumor

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients

Advanced Solid Tumors

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC

Colorectal Carcinoma

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Acute Myeloid Leukemia and Myelodysplastic Syndrome

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of QL1706 Plus Lenvatinib in Subjects With Advanced Renal Cell Carcinoma(RCC)

Advanced Renal Cell Carcinoma
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors

Lymphoma, Non-Hodgkin | Solid Tumor

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety

Metastatic Colorectal Cancer

China
Qilu Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fed Healthy Volunteers

Healthy Volunteers

China
Qilu Pharmaceutical Co., Ltd.

Active, not recruiting

A Study of QL1706 in Subjects With Advanced Malignant Tumor

Advanced Malignant Tumor

China
Qilu Pharmaceutical Co., Ltd.

Active, not recruiting

A Phase I Study of QL1604 for Advanced Solid Tumors

Advanced Solid Tumor

China
Qilu Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia

Primary Immune Thrombocytopenia

China
Qilu Pharmaceutical Co., Ltd.

Completed

A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Wet Age-related Macular Degeneration

China
Qilu Pharmaceutical Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD)

Healthy

China
Qilu Pharmaceutical Co., Ltd.

Unknown

A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Qilu Pharmaceutical Co., Ltd.

Unknown

To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors

Bone Metastases

China
Qilu Pharmaceutical Co., Ltd.

Unknown

An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b

Chronic Hepatitis b

China
Qilu Pharmaceutical Co., Ltd.

Unknown

Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture Risk

Postmenopausal Osteoporosis

China
Qilu Pharmaceutical Co., Ltd.

Completed

Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults

Healthy People

China
Qilu Pharmaceutical Co., Ltd.

Unknown

A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINA (QL-007)

Chronic Hepatitis b

China
Qilu Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer

Non-squamous Non-small Cell Lung Cancer

China
Qilu Pharmaceutical Co., Ltd.

Unknown

A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients

Chronic Hepatitis b

New Zealand
Qilu Pharmaceutical Co., Ltd.

Unknown

A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition (Capecitabine)

Breast Cancer | Colon Cancer
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults

Tumor

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-Avastin® in Healthy Volunteers

Tumor

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of QL1706H in Patients With Advanced Solid Tumors

Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of Olanzapine in Patients With Acute Agitation

Acute Agitation
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer

To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

COVID-19

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19

COVID-19

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma

Advanced Liver Cancer

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer

Cervical Cancer

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation

Non-small Cell Lung Cancer

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study of QLS1128 and in Combination With Ritonavir in Healthy Participants

COVID-19

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study of QLS31905 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections

Acute Pyelonephritis | Complicated Urinary Tract Infection
Qilu Pharmaceutical Co., Ltd.

Recruiting

QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors

Advanced Malignant Tumor

China
Qilu Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers

Healthy Volunteers

China
Qilu Pharmaceutical Co., Ltd.

Active, not recruiting

A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Qilu Pharmaceutical Co., Ltd.

Completed

Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia

China
Qilu Pharmaceutical Co., Ltd.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of QL1706 Injection in Patients With Solid Tumors

Advanced Solid Tumors

China
Qilu Pharmaceutical Co., Ltd.

Completed

Single Dose Mass Balance Study With [14C]Iruplinalkib (WX-0593) In Healthy Male Volunteers

Healthy

China
Qilu Pharmaceutical Co., Ltd.

Active, not recruiting

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer

Cervical Cancer

China
Qilu Pharmaceutical Co., Ltd.

Unknown

Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults

Healthy People

China
Qilu Pharmaceutical Co., Ltd.

Completed

Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet AMD

Wet Age-related Macular Degeneration

China

3

Subscribe